Analyst Price Targets — PBH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 30, 2026 5:48 pm | Keith Devas | Jefferies | $66.00 | $64.18 | TheFly | Prestige Consumer price target lowered to $66 from $70 at Jefferies |
| October 27, 2025 11:40 am | — | Jefferies | $71.00 | $61.96 | TheFly | Prestige Consumer price target lowered to $71 from $75 at Jefferies |
| November 5, 2024 12:26 pm | SUsan Anderson | Canaccord Genuity | $86.00 | $74.58 | StreetInsider | Presitge Brands (PBH) PT Raised to $86 at Canaccord Genuity |
| June 21, 2024 6:15 am | Linda Bolton Weiser | D.A. Davidson | $93.00 | $68.13 | StreetInsider | DA Davidson Defending Presitge Brands (PBH), Uprades to Buy |
| November 17, 2022 6:06 am | — | Canaccord Genuity | $71.00 | $58.35 | Benzinga | Canaccord Genuity Initiates Coverage On Prestige Consumer with Buy Rating, Announces Price Target of $71 |
Latest News for PBH
National survey commissioned by DenTek, the #1 OTC dental guard brand for nighttime teeth grinding, finds nearly 8 in 10 football fans keep thinking about the game after it ends, with many reporting stress-related behaviors that extend into bedtime. NFL legends Ronde & Tiki Barber join DenTek to encourage fans to recognize when football stress may be affecting more than just game day.
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Prestige Brand Holdings is recalling 39,060 bottles of certain Clear Eyes drops over sterility concerns, according to a Food and Drug Administration report.
Amylyx Pharmaceuticals, Inc. is upgraded to Strong Buy after positive phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia [PBH]. Avexitide met its primary endpoint, achieving a 55% reduction in severe hypoglycemic events, with strong statistical significance and a favorable safety profile. Key catalysts include an NDA submission for avexitide in PBH by end-2026 and medical data presentation in…
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for PBH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.